 The group said its separately listed dialysis unit, Fresenius Medical Care, showed very strong earnings growth and exceptional cash flow in the quarter. For 2020, Fresenius expects adjusted net income change between a negative 4 and a positive 1, and revenue growth in the range of 3 to 6, compared to its previous forecast for growth between 1 to 5 and 4 to 7, respectively, which did not account for the pandemics effects. Fresenius second-quarter net income came in at 410 million euros 482.6 million, above analysts average forecast of 398 million euros, according to a company-provided poll. 